Foundayo (Orforglipron): What to Know About This New GLP-1 Weight Loss Pill
For the first time in decades, people looking to manage their weight have a genuinely new kind of option. On April 1, 2026, the U.S. Food and Drug Administration approved Foundayo (orforglipron), an oral once-daily pill in the GLP-1 class — and the first of its kind that can be taken at any time of…
How to Use WiseRX®® Coupons on Brand-Name Medications at the Pharmacy?
Anyone who has stood at a pharmacy counter and watched a cashier read out a three-digit number for a month’s supply of a brand-name medication knows the feeling. You hand over your insurance card, wait, and then hear a price that still doesn’t quite make sense — even with coverage. For people without insurance, or…
Why ProQuad Matters Now: Measles Prevention and Rising Case Concerns
In recent years, public health experts have raised growing concerns about the return of measles in several parts of the world. Once considered largely under control in many countries due to successful vaccination programs, measles is now reappearing in outbreaks, particularly in communities with lower vaccination rates. Health officials emphasize that vaccination remains the most…
